Danaher, an innovator of science and technologies, announced that it has entered into a definitive agreement to acquire UK-based Abcam, a supplier of protein consumables, for approximately $5.7 billion ($24.00 per share). Under the agreement, Abcam will operate as a standalone operating company and brand within the life sciences segment of Danaher. Source: Biopharm International 29/8/2023